Keisuke Kawamoto

1.2k total citations
48 papers, 646 citations indexed

About

Keisuke Kawamoto is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Keisuke Kawamoto has authored 48 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 14 papers in Immunology. Recurrent topics in Keisuke Kawamoto's work include Lymphoma Diagnosis and Treatment (20 papers), T-cell and Retrovirus Studies (9 papers) and Viral-associated cancers and disorders (9 papers). Keisuke Kawamoto is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), T-cell and Retrovirus Studies (9 papers) and Viral-associated cancers and disorders (9 papers). Keisuke Kawamoto collaborates with scholars based in Japan, Greece and United States. Keisuke Kawamoto's co-authors include Hiroaki Miyoshi, Koichi Ohshima, Noriaki Yoshida, Jun Takizawa, Yuya Sasaki, Hirohito Sone, Masao Seto, Joji Shimono, Daisuke Kurita and Kyohei Yamada and has published in prestigious journals such as Blood, Annals of the Rheumatic Diseases and The American Journal of Surgical Pathology.

In The Last Decade

Keisuke Kawamoto

44 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keisuke Kawamoto Japan 14 279 245 215 142 99 48 646
Joji Shimono Japan 12 222 0.8× 242 1.0× 180 0.8× 96 0.7× 25 0.3× 34 503
Yuya Sasaki Japan 12 194 0.7× 185 0.8× 156 0.7× 66 0.5× 43 0.4× 26 403
Kensaku Sato Japan 16 493 1.8× 427 1.7× 194 0.9× 213 1.5× 18 0.2× 27 760
Morgane Cheminant France 12 123 0.4× 125 0.5× 149 0.7× 51 0.4× 68 0.7× 31 480
Liuyan Jiang United States 13 379 1.4× 284 1.2× 164 0.8× 123 0.9× 80 0.8× 79 666
B Varet France 12 260 0.9× 227 0.9× 194 0.9× 222 1.6× 376 3.8× 46 874
Yoshihito Hayami Japan 13 197 0.7× 154 0.6× 161 0.7× 99 0.7× 155 1.6× 26 583
Kae Shimazaki Japan 13 298 1.1× 185 0.8× 130 0.6× 58 0.4× 68 0.7× 18 510
Hiroshi Ureshino Japan 12 80 0.3× 120 0.5× 127 0.6× 89 0.6× 200 2.0× 75 433
Kazuyoshi Kajimoto Japan 13 162 0.6× 152 0.6× 80 0.4× 67 0.5× 70 0.7× 45 488

Countries citing papers authored by Keisuke Kawamoto

Since Specialization
Citations

This map shows the geographic impact of Keisuke Kawamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Kawamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Kawamoto more than expected).

Fields of papers citing papers by Keisuke Kawamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Kawamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Kawamoto. The network helps show where Keisuke Kawamoto may publish in the future.

Co-authorship network of co-authors of Keisuke Kawamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Kawamoto. A scholar is included among the top collaborators of Keisuke Kawamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Kawamoto. Keisuke Kawamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Ken, Hiroaki Miyoshi, Keisuke Kawamoto, et al.. (2023). Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients: CD47 expression is a favourable prognostic factor. Pathology. 56(1). 81–91. 2 indexed citations
2.
Miyoshi, Hiroaki, Keisuke Kawamoto, Mai Takeuchi, et al.. (2021). Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation. Pathology. 54(4). 442–448. 6 indexed citations
3.
Kawamoto, Keisuke, Takaharu Suzuki, Tatsuya Suwabe, et al.. (2021). DA-EPOCH-R therapy for high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangements in a patient with renal dysfunction. Journal of Clinical and Experimental Hematopathology. 61(1). 42–47. 1 indexed citations
4.
Takeuchi, Mai, Hiroaki Miyoshi, Kazutaka Nakashima, et al.. (2020). Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia/lymphoma. Annals of Hematology. 99(5). 1093–1098. 13 indexed citations
5.
Yoshida, Noriaki, Hiroaki Miyoshi, Fumiko Arakawa, et al.. (2020). Cytokine‐related genes play critical roles in extrafollicular growth of follicular lymphoma cells. Hematological Oncology. 38(5). 673–679. 2 indexed citations
6.
Nishikawa, Nagahiro, et al.. (2019). Transient severe conduction disturbances associated with ankylosing spondylitis. Journal of Arrhythmia. 35(4). 689–691. 2 indexed citations
7.
Kawamoto, Keisuke, Masae Sakuma, Masashi Masuda, et al.. (2019). High-fat diets provoke phosphorus absorption from the small intestine in rats. Nutrition. 72. 110694–110694. 8 indexed citations
8.
Suzuki, Takaharu, Hiroaki Miyoshi, Eriko Yanagida, et al.. (2019). CLINICOPATHOLOGICAL DIFFERENCES OF NODAL PTCL WITH TFH PHENOTYPE FROM AITL AND PTCL, NOS, AND DETECTION OF PROGNOSTIC MARKER OF NODAL PTCL WITH TFH PHENOTYPE. Hematological Oncology. 37(S2). 276–277. 2 indexed citations
9.
Kawamoto, Keisuke, Hiroaki Miyoshi, Takaharu Suzuki, et al.. (2018). Cladribine treatment for Erdheim–Chester disease involving the central nervous system and concomitant polycythemia vera: A case report. Journal of Clinical and Experimental Hematopathology. 58(4). 161–165. 9 indexed citations
10.
Kawamoto, Keisuke, Hiroaki Miyoshi, Takaharu Suzuki, et al.. (2018). Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patients. Hematological Oncology. 36(3). 591–599. 13 indexed citations
11.
Yanagida, Eriko, Hiroaki Miyoshi, Keisuke Kawamoto, et al.. (2018). Clinicopathological analysis of immunohistochemical expression of retinoic acid–related orphan receptor-γt in peripheral T-cell lymphoma, not otherwise specified. Human Pathology. 79. 86–92. 2 indexed citations
12.
Kawamoto, Keisuke, Hiroaki Miyoshi, Eriko Yanagida, et al.. (2017). Comparison of clinicopathological characteristics between T‐cell prolymphocytic leukemia and peripheral T‐cell lymphoma, not otherwise specified. European Journal Of Haematology. 98(5). 459–466. 9 indexed citations
13.
14.
Kawamoto, Keisuke, Hiroaki Miyoshi, Takaharu Suzuki, et al.. (2017). Frequent expression of CD30 in extranodal NK/T‐cell lymphoma: Potential therapeutic target for anti‐CD30 antibody‐based therapy. Hematological Oncology. 36(1). 166–173. 28 indexed citations
15.
Shimono, Joji, Hiroaki Miyoshi, Fumiko Arakawa, et al.. (2017). Prognostic factors for histiocytic and dendritic cell neoplasms. Oncotarget. 8(58). 98723–98732. 20 indexed citations
16.
Kawamoto, Keisuke, Hiroaki Miyoshi, Noriaki Yoshida, et al.. (2016). Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients. The American Journal of Surgical Pathology. 40(11). 1473–1483. 71 indexed citations
17.
Asano, Naoko, Hiroaki Miyoshi, Takeharu Kato, et al.. (2016). Expression Pattern of Immunosurveillance-Related Antigen Is a Critical Prognostic Factor of Adult T-Cell Leukemia/Lymphoma. Blood. 128(22). 4135–4135. 1 indexed citations
18.
Higuchi, Takakazu, et al.. (2015). Acquired β-Thalassemia as an Etiology of Microcytic Anemia in Primary Myelofibrosis. Journal of Hematology. 4(1). 148–150.
19.
Nakahara, Hideko, Masayuki Nishide, Keisuke Kawamoto, et al.. (2012). Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab. Modern Rheumatology. 23(2). 276–283. 8 indexed citations
20.
Nakahara, Hideko, Yosuke Kamide, Takashi Hosokawa, et al.. (2011). A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment. Modern Rheumatology. 21(6). 655–659. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joji Shimono Breakdown of academic impact, for papers by Yuya Sasaki Breakdown of academic impact, for papers by Kensaku Sato Breakdown of academic impact, for papers by Morgane Cheminant Breakdown of academic impact, for papers by Liuyan Jiang Breakdown of academic impact, for papers by B Varet Breakdown of academic impact, for papers by Yoshihito Hayami Breakdown of academic impact, for papers by Kae Shimazaki Breakdown of academic impact, for papers by Hiroshi Ureshino Breakdown of academic impact, for papers by Kazuyoshi Kajimoto
Rankless by CCL
2026